AVAVAVAV

Investment Thesis

AeroVironment is a multi-product drone and counter-UAS company with two flagship product lines: LOCUST directed-energy counter-UAS systems and Switchblade loitering munitions. The investment thesis rests on a single secular trend: the globalization of counter-UAS procurement. For decades, the US military owned air superiority by default. That is no longer true. Drone swarms and cheap quadcopters are now the leveling technology for near-peer and peer-armed forces, and the only reliable counter is an integrated C-UAS (counter-Unmanned Aircraft System) capability that combines detection, targeting, and kill chains. AVAV owns two proven solutions in that chain: the Switchblade loitering munition (combat-proven in Ukraine, now program-of-record with US Army) and LOCUST X3 directed-energy laser system (approaching program-of-record status after White Sands live-fire validation by Army Secretary Driscoll in May 2026).

The market opportunity is enormous and accelerating. A $2B NATO Denmark counter-UAS contract awarded to Anduril in March 2026 is not a win for Anduril alone—it is proof that counter-UAS budgets are real and scaling at the allied defense level. AVAV is the incumbent with combat-proven munitions and an approaching directed-energy system. Yet despite confirmed $1.2B funded backlog, record Q4 FY2026 revenue of $641.6M (up 133% YoY), and a $117M Army contract confirmed June 3, 2026, AVAV trades 60% below its 52-week high. The disconnect is driven by macro tape action and a class action lawsuit, not by fundamental deterioration.

FY2027 EPS guidance of $3.02–$3.34 suggests management is being intentionally conservative in the face of macro uncertainty and legal risk. If the company even approaches consensus estimates of ~$4.00, the stock is materially undervalued.

Physical AI / Value-Chain Relevance

Layer(s): Autonomy Software, Fleet Platforms & End Markets | Perception (LiDAR/optical)

Technology(ies): Directed energy counter-UAS (vehicle-mounted HEL) | Digital CMOS LiDAR | Loitering munition guidance systems

AeroVironment sits at the highest level of the Physical AI stack—the end-market autonomy layer where intelligence, sensing, and actuation come together as an integrated platform. LOCUST X3 is a vehicle-mounted laser that autonomously tracks, discriminates, and neutralizes UAS threats using onboard perception (optics, possibly LiDAR). Switchblade is an autonomous loitering munition that can be deployed without continuous human guidance, navigating and targeting via onboard sensors. Both require embedded edge compute, perception systems, and decision-making algorithms—the full stack of Physical AI compressed into a tactical form factor.

AVAV is not a component supplier. It is a vertically integrated prime contractor that owns the entire value chain from sensor package through autonomous guidance to the lethal payload. This is precisely where the physical-AI transition creates durable, defensible advantage: at the layer where physics, autonomy, and integration determine success or failure. Competitors (Anduril, Shield AI, Joby) are capable, but AVAV's advantage is not technical—it is operational. Combat-proven Switchblade with five years of field data and battle-hardened autonomous guidance gives AVAV an empirical edge that no amount of capital or engineering can quickly replicate.

Catalysts

Near-term (3–6 months):

1. LOCUST E-HEL program award ($500M+ anticipated) — Army is actively evaluating the directed-energy C-UAS system. A formal program-of-record award would unlock a multi-year production contract and validate the technology as the DoD's preferred directed-energy approach.
2. Q4 FY2027 earnings and FY2028 guidance — Management commentary on backlog conversion, LOCUST production ramp, and Switchblade international orders will reset market expectations on near-term growth.
3. Switchblade international military sales announcements — Allied nations are adopting loitering munitions. Each new customer order (France, Poland, Romania, others) proves the procurement wave is real and accelerating.

Medium-term (6–12 months):

1. White House/DoD C-UAS strategy announcement — If the Federal government formally prioritizes counter-UAS as a national security priority (following the recent drone incursions), procurement budgets will increase and AVAV will be the primary beneficiary.
2. New C-UAS integrator wins — Northrop, Raytheon, or other large defense primes may license or integrate LOCUST into their own C-UAS solutions, expanding AVAV's addressable market.

Positioning / What the Market May Be Missing

The core insight: AVAV is a double-optionality play on defense autonomy that the market is pricing at a single-optionality discount. The street is focused on one product (Switchblade) and underweighting the upcoming directed-energy catalyst (LOCUST). The class action lawsuit is real, but it is a near-term overhang, not a fundamental business issue. Legal risk is temporary; the procurement wave is multi-year.

Additionally, BlackRock reduced its position by 12.5% in Q1 2026, which spooked the tape. This is textbook institutional rebalancing for a mega-cap fund, not a signal of deteriorating fundamentals. It is noise that creates opportunity for investors with a medium-term horizon.

The market may also be underestimating the economics of directed-energy C-UAS. Per-shot cost is ~$5 for a laser vs. $500K+ for a traditional interceptor missile. This is the physics of the opportunity: a 100x cost advantage that no procurement bureaucrat can ignore once the system is validated. LOCUST X3 is that validation.

Risks and What Invalidates the Thesis

Thesis invalidation scenarios:

• Anduril or Shield AI win the next large C-UAS contract award — If a competitor is selected for the E-HEL program or a new counter-UAS competition, market confidence in AVAV's technology would be shaken, and procurement momentum could reverse.
• LOCUST directed-energy system reliability issues — If White Sands or field testing reveals technical issues with the laser system (power, range, target discrimination), the program-of-record path could be delayed or cancelled.
• DoD budget cuts to small-UAS or counter-UAS programs — A Continuing Resolution through FY2027 or broader defense reductions could push procurement timelines out beyond current expectations.
• Class action lawsuit escalation — If the lawsuit reveals material operational or accounting issues, the stock could face a sharp reset. Monitor settlement progress and discovery outcomes.
• Margin failure — If production ramps faster than expected and yield issues or supply chain constraints compress gross margins, the earnings leverage story breaks.

Key monitoring:

• Weekly drone/C-UAS news for competitive announcements or procurement updates.
• Quarterly earnings for backlog conversion rates and LOCUST program commentary.
• SEC filings for class action status updates.

What to Watch Next

1. LOCUST E-HEL Program-of-Record Status — When will the Army formally adopt LOCUST X3 as the baseline directed-energy C-UAS system? A mid-2026 or late-2026 announcement would be highly positive.
2. Q4 FY2027 Earnings (expected September 2026) — Will management raise FY2028 guidance to reflect the $117M June contract and confidence in LOCUST adoption?
3. Switchblade International Orders — How many allied nations are queuing up for loitering munitions? A series of foreign military sales would confirm the procurement wave is real.
4. JLTV-Mounted LOCUST Deliveries — The Army is integrating LOCUST X3 into Joint Light Tactical Vehicles (JLTV). When do actual hardware deliveries begin, and in what volume?
5. Competitive Landscape — What is Anduril doing with its $2B NATO contract? Is Northrop or Raytheon making counter-UAS moves that could displace AVAV?

Market Position: Market cap $8.66B | Forward P/E 43.05 | Price $142.12 | Target $240 (+69% upside)